A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

This study has been terminated.

Sponsor:

Collaborator:

Pfizer

Information provided by (Responsible Party):

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

ClinicalTrials.gov Identifier:

NCT00937352

First received: July 7, 2009

Last updated: August 24, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	September 2012
Estimated Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)